A simple, selective and rapid validated method for estimation of anastrazole in human plasma by liquid chromatography-tandem mass spectrometry and its application to bioequivalence study

Biomedical Chromatography

Volumn 24, Issue 7, 2010, Pages 727-731

  Jangid, Arvind G ^a,b   Pudage, Ashutosh M ^b   Joshi, Santosh S ^b   Pabrekar, Pramod N ^c   Tale, Rajesh H ^a   Vaidya, Vikas V ^a  

^a Accutest Research Laboratories I Pvt Ltd   (India)

^b SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

^c Mumbai University   (India)

Author keywords

Anastrazole; Human plasma; LC MS MS; Letrozole

Indexed keywords

DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN); POSITIVE IONS;

ANASTRAZOLE; BIOEQUIVALENCE STUDY; HUMAN PLASMAS; INTERNAL STANDARDS; LC-MS-MS; LC.MS/MS; LETROZOLE; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; SIMPLE++; VALIDATED METHODS;

PHASE SEPARATION;

ACETONITRILE; ANASTROZOLE; FORMIC ACID; LETROZOLE; WATER;

ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG STRUCTURE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

EID: 77953526505     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1354     Document Type: Article

References (10)

1. Apostolou C, Dotsikas Y, Kousoulos C and Loukas YL. Development and validation of an high-throughput method for the determination of anastrazole in human plasma by LC-MS/MS and atmospheric pressure chemical ionization. Journal of Pharmaceutical Biomedical Analysis 2008; 48(3):853-859.
2. Bock MJ, Bara I, LeDonne N, Martz A and Dyroff M. Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography-63Ni electron capture detection. Journal of Chromatography B: Biomedical Sciences and Applications 1997; 700:131-138.
3. Brodie AM. Aromatase inhibitors in the treatment of breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 1994; 49: 281-287. (Pubitemid 24240612)
4. Buzdar A, Jonat W, Howell A, Jones SE, Blomqvist C and Vogel CL. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials, Arimidex Study Group. Journal of Clinical Oncology 1996; 14: 2000-2011.
5. Dixon JM, Love CD, Renshaw L, Bellamy C, Cameron DA and Miller WR. Lessons from the use of aromatase inhibitors in the neoadjuvant setting. Endocrine-related Cancer 1999; 6: 227-230. (Pubitemid 29260056)
6. Duan G, Liang J and Zuo M. Rapid determination of anastrozole in plasma by gas chromatography with electron capture detection and its application to an oral pharmacokinetic study in healthy volunteers. Biomedical Chromatography 2002; 16: 400-403.
7. Geisler J, King N, Dowsett M, Ottestad L, Lundgren S, Walton P, Kormeset PO and Lønning PE. Influence of anastrozole (Arimidex® ), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in post-menopausal women with breast cancer. British Journal of Cancer 1996, 74: 1286-1291. (Pubitemid 26360121)
8. Mareck U, Geyer H, Guddat S, Haenelt N, Koch A, Kohler M, Opfermann G, Thevis M and Schanzer W. Identification of the aromatase inhibitors anastrazole and exemastane in human urine using liquid chromatography/ tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2006; 20(6): 1954-1962. (Pubitemid 43893351)
9. Mendes GD, Hamamoto D, Ilha J, Pereira ADS and Nucci GD. Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies. Journal of Chromatography B 2007; 850: 553-559.
10. Yuan J, Wang PQ, Ge SR, An FR, Shi AG, Chen J and Liang JY. Pharmacokinetics of anastrazole in Chinese male volunteers. Acta Pharmacologica Sinica 2001; 22(6): 573-576.